Rare disease therapeutic development and access
2025 · 2nd Quarter (Apr 1 - June 30)
SAREPTA THERAPEUTICS
Filed by MICHAEL BEST STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- MICHAEL BEST STRATEGIES LLC
- Client
- SAREPTA THERAPEUTICS
- Filing UUID
- c00bbdd4-cfaa-4e8e-bd1e-6914a26b6033
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Rare disease therapeutic development and access
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.